Genomic-led AML Clinical Decision Making Within Seven Days

Genomic-led AML Clinical Decision Making Within Seven Days

31/12/2019

The “Beat AML” study assesses an algorithm screening for genomic features in order to choose appropriate targeted therapies for individual patients with their specific form of AML